作者:
Pitt,B. [1]
;
Filippatos,G. [2]
;
Gheorghiade,M. [3]
;
Kober,L. [4]
;
Krum,H. [5]
;
Ponikowski,P. [6]
;
Nowack,C. [7]
;
Kolkhof,P. [8]
;
Kim,S.-Y. [9]
;
Zannad,F. [10]
作者单位:
Cardiology Research, Department of Heart Diseases, Global Drug Discovery, Bayer HealthCare
[1]
Heart Centre, Rigshospitalet, University of Copenhagen, Denmark
[2]
Heart Failure Unit, Department of Cardiology, Attikon University Hospital, Athens, Greece
[3]
Department of Epidemiology and Preventive Medicine, Centre of Cardiovascular Research and Education
[4]
University of Michigan School of Medicine, Ann Arbor, MI 48109-0366, United States
[5]
INSERM, Centre for Clinical Investigation 9501, Central University Hospital, Nancy, France
[6]
Center for Cardiovascular Innovation, Northwestern University Feinberg School of Medicine, Chicago
[7]
Bayer Vital GmbH, Bayer HealthCare, Leverkusen, Germany
[8]
Medical University, Clinical Military Hospital, Wroclaw, Poland
[9]
Global Clinical Development, Bayer Pharma AG, Wuppertal, Germany
[10]
发布时间
2013-11-20